Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Dermatological Medicine
Volume 2016, Article ID 3793986, 4 pages
http://dx.doi.org/10.1155/2016/3793986
Case Report

A Case of Hereditary Leiomyomatosis and Renal Cell Carcinoma

University College London Hospital, 235 Euston Road, London NW1 2BU, UK

Received 10 January 2016; Revised 13 March 2016; Accepted 22 March 2016

Academic Editor: Jaime A. Tschen

Copyright © 2016 Sarah Mehrtens et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Launonen, O. Vierimaa, M. Kiuru et al., “Inherited susceptibility to uterine leiomyomas and renal cell cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 6, pp. 3387–3392, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. J. J. Emer, S. Solomon, and S. E. Mercer, “Reed's syndrome: a case of multiple cutaneous and uterine leiomyomas,” Journal of Clinical and Aesthetic Dermatology, vol. 4, no. 12, pp. 37–42, 2011. View at Google Scholar · View at Scopus
  3. N. A. Alam, S. Olpin, and I. M. Leigh, “Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer,” British Journal of Dermatology, vol. 153, no. 1, pp. 11–17, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. I. P. M. Tomlinson, N. A. Alam, A. J. Rowan et al., “Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer,” Nature Genetics, vol. 30, no. 4, pp. 406–410, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. M.-H. Wei, O. Toure, G. M. Glenn et al., “Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer,” Journal of Medical Genetics, vol. 43, no. 1, pp. 18–27, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. Y.-B. Chen, A. R. Brannon, A. Toubaji et al., “Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry,” The American Journal of Surgical Pathology, vol. 38, no. 5, pp. 627–637, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. M. J. Merino, C. Torres-Cabala, P. Pinto, and W. Marston Linehan, “The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome,” The American Journal of Surgical Pathology, vol. 31, no. 10, pp. 1578–1585, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. H. J. Lehtonen, M. Kiuru, S. K. Ylisaukko-Oja et al., “Increased risk of cancer in patients with fumarate hydratase germline mutation,” Journal of Medical Genetics, vol. 43, no. 6, pp. 523–526, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Gardie, A. Remenieras, D. Kattygnarath et al., “Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma,” Journal of Medical Genetics, vol. 48, no. 4, pp. 226–234, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. I. Alrashdi, S. Levine, J. Paterson et al., “Hereditary leiomyomatosis and renal cell carcinoma: very early iagnosis of renal cancer in a paediatric patient,” Familial Cancer, vol. 9, no. 2, pp. 239–243, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. V. M. Raymond, C. M. Herron, T. J. Giordano, and S. B. Gruber, “Familial renal cancer as an indicator of hereditary leiomyomatosis and renal cell cancer syndrome,” Familial Cancer, vol. 11, no. 1, pp. 115–121, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. M. H. Wong, C. S. Tan, S. C. Lee et al., “Potential genetic anticipation in hereditary leiomyomatosis-renal cell cancer (HLRCC),” Familial Cancer, vol. 13, no. 2, pp. 281–289, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. F. H. Menko, E. R. Maher, L. S. Schmidt et al., “Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment,” Familial Cancer, vol. 13, no. 4, pp. 637–644, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. G. S. Chuang, A. Martinez-Mir, A. Geyer et al., “Germline fumarate hydratase mutations and evidence for a founder mutation underlying multiple cutaneous and uterine leiomyomata,” Journal of the American Academy of Dermatology, vol. 52, no. 3, pp. 410–416, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. N. A. Alam, E. Barcaly, A. J. Rowman et al., “Clinical features of multiple cutaneous and uterine leiomyomatosis: an underdiagnosed syndrome,” Archives of Dermatology, vol. 141, pp. 199–206, 2005. View at Google Scholar
  16. D. L. Smit, A. R. Mensenkamp, S. Badeloe et al., “Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis,” Clinical Genetics, vol. 79, no. 1, pp. 49–59, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. J. R. Toro, M. L. Nickerson, M.-H. Wei et al., “Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America,” The American Journal of Human Genetics, vol. 73, no. 1, pp. 95–106, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. L. J. Christenson, K. Smith, and C. J. Arpey, “Treatment of multiple cutaneous leiomyomas with CO2 laser ablation,” Dermatologic Surgery, vol. 26, no. 4, pp. 319–322, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. R. J. Batchelor, C. C. Lyon, and A. S. Highet, “Successful treatment of pain in two patients with cutaneous leiomyomata with the oral alpha-1 adrenoceptor antagonist, doxazosin,” British Journal of Dermatology, vol. 150, no. 4, pp. 775–776, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Alam, A. D. Rabinowitz, and D. E. Engler, “Gabapentin treatment of multiple piloleiomyoma-related pain,” Journal of the American Academy of Dermatology, vol. 46, no. 2, pp. S27–S29, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Onder and E. Adişen, “A new indication of botulinum toxin: leiomyoma-related pain,” Journal of the American Academy of Dermatology, vol. 60, no. 2, pp. 325–328, 2009. View at Publisher · View at Google Scholar · View at Scopus